Filters byReset all
Search Criteria : United States of America ×
Nov 04, 2019 - Oct 31, 2020 | CME : 77.75 | Credits : 7.25 | USD $12,900.00 | Boston, Massachusetts
High-Impact Cancer Research Program is organized by Harvard Medical School (HMS). This Onsite medical conference will be held from Nov 04, 2019 - Oct 31, 2020, at Harvard Medical School, Boston, Massachusetts, United States of America. Who Should Apply: This Harvard Medical School program is open to both new and seasoned researchers including professionals in fundamental and clinical research, population health leaders of cancer-focused enterprises including scientific, policy, and financial top-flight trainees. Prospective students should hold a master’s degree in their field of study, a doctoral degree such as Ph.D., or PsyD and/or a professional degree such as an MD, MBBS, DDM, DMD, PharmD, DNP or foreign equivalent degree. What is the credit statement of the High-Impact Cancer Research Program? Accreditation: The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to present continuing medical education for physicians. This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 7.25 credits of Risk Management Study. Live Workshops: The Harvard Medical School designates this live activity for a maximum of 77.75 AMA PRA Category 1 Credits™. Physicians will be able to earn only the credit commensurate with the extent of their participation in the activity. Online Modules: The Harvard Medical School designates this enduring material for a maximum of 52.50 AMA PRA Category 1 Credits™. Physicians will be granted the credit commensurate with the extent of their participation in the activity. What is the significance of the High-Impact Cancer Research Program? Conference Overview: With so many new and promising strategies and recent developments, the opportunities to produce and enable high-impact cancer research are unprecedented. Recent advances continue to expand and reshape our views of the essential features of cancer. We are learning important new aspects of how cancers develop, how to find and diagnose cancers earlier, how to design and unleash powerful new anti-cancer therapies, and how to evaluate cancer risk and even prevent tumors from arising. These advances are delivering useful, productive changes that lead to better cancer outcomes. High-Impact Cancer Research is the acclaimed Harvard Medical School postgraduate certificate program for cancer research. It teaches the principles and skills shaping today’s most important cancer research activities. High-Impact Cancer Research faculty are distinguished leading experts who have achieved breakthroughs in fields from discovery biology to therapeutics and prevention. In this special program, world leaders in cancer research share their insights and teach this changing science. Participants learn the new fundamentals of a wide spectrum of cancer science and the skills necessary to envision, design, and lead cutting-edge cancer research projects that can contribute to these changes. What are the objectives of the High-Impact Cancer Research Program? Conference Objectives: This program is intended to help participants make high-impact contributions that manage to better cancer outcomes. Upon completion of the program, participants will be able to: • Explain the molecular and cellular basis of cancer development, detection, diagnosis, treatment, and prevention • Read about important advances within the context of clinical presentation of various human tumors and ways it is currently being used to develop the growing set of therapeutic and preventive approaches to fighting cancer • Discover about distinct cancer treatments from the individuals who developed the therapies and are testing them in ongoing clinical trials • Hone skills necessary to identify and answer key questions needed to make future contributions and to effectively communicate your ideas and conclusions • Earn critical skills to interpret and assess emerging cancer research • Envision and design cancer research projects • Improve writing skills for personal career advancement (e.g., grant applications or funding requests; the science section of a business plan designed to highlight a particular commercial opportunity; papers suitable for submission and publication) • Form an international network of colleagues and work effectively with international peers Curriculum Highlights This program allows participants to learn directly from Harvard’s leading faculty in discovery biology and clinical tumor development, and from internationally recognized leaders in the cancer research community who have achieved breakthroughs in therapeutics, risk assessment, and prevention. Peer-to-peer learning projects allow participants to learn from one another while producing publication-quality reports on important aspects of cancer research. This also allows each participant to develop a large network of international colleagues who will be resources throughout their career. Students can also customize their learning experience and skills development around their interests and career goals through two optional elective tracks (Communications or Leadership and Management) and an education track for deeper immersion into one of four areas: • Cancer -Omics • Clinically challenging cancers • Risk and prevention • Therapeutic development • Three workshops hosted at Harvard Medical School (Boston, MA): Workshop Dates: • Workshop 1: November 4 – 8, 2019 (Boston) • Workshop 2: April 14 – 18, 2020 (Boston) • Workshop 3: October 26 – 31, 2020 (Boston).
Oct 18 - 25, 2020 | Contact Hours : 14 | USD $350.00 | Boston, Massachusetts
PLEASE NOTE: THIS IS NOT A CURRENTLY ACTIVE PROGRAM. Pain vs. Addiction is organized by Continuing Education, Inc. and will be held from Oct 18 - 25, 2020 at Royal Caribbean's Brilliance of the Seas, Boston, Massachusetts, United States of America. Target Audience: Nurses, Nurse Practitioners Accreditation: • 14.0 Contact Hours Topics: • Physical dependence • Addiction • Differentiating Patients • Types of pain: Acute vs. Chronic • Opioid Use Disorder • Withdrawal Symptoms & Treatments • Behavioral Support Additional details will be posted as soon as information is available.
Oct 26 - 27, 2020 | Boston, Massachusetts
Pre Filled Syringes East Coast 2020 is organized by SMi Group Ltd and will be held from Oct 26 - 27, 2020 at Sheraton Boston Hotel, Boston, Massachusetts, United States of America. Who Should Attend: • Drug-delivery developers • Medical Device Engineers • Primary Packaging material designers • Secondary packagers • Smart device developers • Training device developers • Device-safety solution providers • Drug developers Description: The global pre-filled syringes market was valued at $4.9 billion in 2018 and with the rapid growth of the industry, is expected to exceed $9.7 billion by 2025. With that in mind, this event will bring together specialists within the industry to provide an exclusive insight into the sphere of regulation, new digital technology trends, human studies and innovative design and delivery systems within the prefilled syringe industry. This comprehensive overview will help attendees understand the changing global market and the challenges faced within the industry. Following the success of last year’s event, the upcoming conference will cover key topics driving the industry including: • Container Closure Interaction and Formulation • On-body Injectors • Digital connectivity in the parenteral space • A regulatory outlook with industry and recognised body experts • Patient centricity and device development • Developments in device technology • Parenteral gene therapy • Two interactive Post-Conference Workshops This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more. Benefits of Attending: • EXPLORE the latest case studies parenteral drug delivery • GAIN insights into the use of pre-filled syringes for gene therapy • NETWORK with leading industry experts, key opinion leaders and regulatory body representatives • ENGAGE in the key challenges and topics of the field in the interactive post-conference workshops.
Oct 26 - 28, 2020 | USD $5,497.00 | Boston, Massachusetts
This course is also available as webcast. TCR-based Therapies Summit is organized by Hanson Wade and will be held from Oct 26 - 28, 2020 at Hyatt Regency Boston, Boston, Massachusetts, United States of America. Description: The only dedicated end-to-end, industry led TCR therapy summit is a unique opportunity to delve into the details of TCR development. This technical meeting is a rare opportunity to learn from 20 industry experts from Ziopharm, Immatics US, TScan Therapeutics and many more. Gain insights on their various approaches and be the first to hear cutting-edge data from this fast-paced industry. A 23.1% growth rate since 2009 spells progress in the TCR-Based therapies space. This dedicated meeting brings you the industry leaders pushing the bounds of T Cell therapies. With a building number of Phase 1 and Phase 2 trials on the horizon, stay ahead of this booming field at the TCR-based therapies summit. Covering the most exciting developments and promising clinical data, the TCR-based Therapies Summit will propel your research ahead in 2020 with optimized target identification, supercharged T-cell modifications and insights to the future of manufacturing. For leaders in the TCR space, this is not a meeting to be missed! Join the TCR-Based Therapies Summit this April to discover solutions to: • Identifying the best targets whilst minimizing off-target effects TScan Therapeutics and Affinity Bio will present optimized workflows for target selection and assay development to revolutionize personalized immunotherapy • Bringing autologous therapies to the clinic Experts from Immatics will provide an overview of therapeutics success and explore the relative merits of allogenic, autologous, and potential off-the-shelf therapies of the future • Leveraging the natural biology of TCRs in oncology Eureka Therapeutics will discuss strategies to supercharge TCRs against the hostile tumor microenvironment and create homogenous T cell populations. The TCR-Based Therapies Summit is the only forum for TCR-dedicated discussion. Join these industry leaders to tackle the greatest challenges in TCR therapies and accelerate your solutions to the clinic. Additional details will be posted as soon as information is available.
Oct 28 - 29, 2020 | USD $1,999.00 | Boston, Massachusetts
SMi’s 3rd Annual Conference Pharmaceutical Microbiology East Coast is organized by SMi Group Ltd and will be held from Oct 28 - 29, 2020 at Sheraton Boston Hotel, Boston, Massachusetts, United States of America. Who Should Attend: • Senior Microbiologist • Lead Scientist • Laboratory Manager • QA Specialist • Drug Substance External Manufacturer • QC Scientists • Heads of Quality • Business Development Manager • Pharmaceutical Microbiology Consultant • Higher Pharmacopoeial Scientist • Analytical Standards Specialist Conference Overview: The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, innovative approaches in ATMP facilities, this industry is ever expanding. Join industry experts to discuss and analyze the latest advances and challenges within the industry. Network with industry professionals, discuss revisions in regulatory and guidance documents, explore data integrity considerations for conventional and rapid microbiology methods, analyze arising issues with environmental monitoring to best control contamination and gain insight into an industry perspective on automated endotoxin testing and process automation. Benefits of Attending: Highlights for 2020: • Discuss ongoing complication of personnel derived contaminations from the FDA • Gain valuable insight towards microbiological quality considerations in non-sterile manufacturing and control of BCC from Parexel • Learn from the perspective of the US Pharmacopeia on container closure integrity evaluation • Examine an end-to-end contamination risk assessment for autologous cell therapy from Juno Therapeutics • Explore a back to back Genentech session covering technical considerations for microbial QC of raw materials used in biotechnology and the past, current and future state of Mycoplasma testing Additional details will be posted as soon as information is available.
Oct 31 - Nov 07, 2020 | Boston, Massachusetts
2020 IEEE Nuclear Science Symposium (NSS) and Medical Imaging Conference (MIC) together with the 27th Symposium on Room-Temperature X- and Gamma-Ray Detectors is organized by IEEE Nuclear & Plasma Sciences Society (NPSS). The session will be held from Oct 31 - Nov 07, 2020. Venues: Westin Boston Waterfront Hotel and the Boston Convention and Exhibition Center in Boston, Massachusetts, USA. NSS Program & Topics: The NSS session has been leveraging from the past years on the most current trends in detector technology, radiation detection, detector materials, new instrumentation techniques, and their implementation in high energy, nuclear physics, astrophysics, accelerators, national nuclear security, and several other charges in various radiation conditions. As various developments have strong overlaps in their fields, joint assemblies are incorporated with the MIC and RTSD. Workshops that will incorporate fields of specific areas of interest are arranged. Short assemblies on a distinct traditional as well as novel topics of interest to the NSS community are also being offered. The conference invites the Authors to impersonate papers explaining the original unpublished work on the following topics: Electronics and Methods • Analog and Digital Circuits • DAQ, Trigger, and Front-End Electronics Systems • Modeling, Algorithms, and Data Analysis (Monte Carlo modeling of nuclear systems, algorithms for digital data analysis) Neutron and Gamma-ray Imaging (Single-particle and dual particle imaging) Detector Development • Photodetectors (PMTS, SiPMs, etc.) • Organic Scintillators (Growth, new materials, applications • Inorganic Scintillators (Growth, new materials, applications) • Semiconductor and Gaseous Detectors (Growth, new materials, applications) • Unconventional Detectors (LXe, LAr, antineutrino, muon, etc.) Applications • Nonproliferation, National, and Homeland Security (Safeguards, treaty verification, contraband detection) • Nuclear and High-Energy Physics, and Astrophysics (Accelerator, FEL and beamline instrumentation • Space applications • Radiation Damage Effects and Rad-Hard Devices • Dosimetry and Reactor Applications MIC Program & Topics: The IEEE Medical Imaging Conference (MIC) is the most famous international scientific conference addresses the trends in physics, engineering, and mathematical aspects of medical imaging. Medical imaging is a robustly progressing realm where technological advances in detectors and instrumentation and modern computational methods have paved the way towards advancement in detection, diagnosis, treatment, and monitoring. MIC 2020 has a unique approach to leading-edge research in multiple modalities of imaging, design, and implementation of new hardware and software techniques, their implementation in the clinical practice. In recent years the demand for applications such as machine learning and AI and other fast-emerging research areas has been increased. The session is organized for students, post-doctoral fellows, and junior and senior researchers from across the world to join hands, collaborate, and share ideas, innovations, and the outcomes of the scientific endeavors. MIC 2020 Topics: • Recent innovations on radiation detector technologies for medical imaging • Simulation and modelling of medical imaging systems • Clinical emission imaging systems • X-ray and CT imaging systems • Multi-modality imaging systems • High-resolution imaging systems (small-animal, brain, intra-operative, etc.) • Other imaging technologies (optical, MR, etc.) • Tomographic imaging reconstruction methods • Signal processing, image analysis, and quantitative imaging techniques • Imaging in radiotherapy, hadron therapy, image-guided interventions • Parametric imaging and tracer kinetic modeling • Assessment and comparison of image quality and methods RTSD Program & Topics: The 27th International Symposium on Room-Temperature Semiconductor Detectors (RTSD) is the most comprehensive forum of scientists and engineers devising new solid-state radiation detectors and imaging arrays. Room-temperature semiconductor radiation detectors remain to explore emerging applications in well-defined fields such as medicine, homeland security, astrophysics, and environmental remediation. The purpose of this symposium is to present an assembly for consideration of the state-of-the-art of the detector technology, along with the materials improvement, material and device characterizations, fabrication, electronics, and applications. To manage a thorough review, oral and poster presentations representing a broad spectrum of research and advancement activities featuring room-temperature-operating semiconductor detectors or imaging tools are sought. Authors are encouraged to submit abstracts on original work in the following RTSD-related areas: • X-ray and gamma-ray spectroscopic detectors and systems • Crystal growth and material characterization for radiation detectors • Pixel and strip detectors • Electrical contacts and device fabrication technology • Radiation damage, Long-term stability, and Environmental effects • Organic and perovskite materials for radiation detection • Semiconductor neutron detectors • Imaging systems and applications • Spectrometer systems for homeland security, nuclear inspections, safeguards, portal monitoring, and other uses.
Feb 20 - 24, 2021 | Boston, Massachusetts
Biophysical Society 65th Annual Meeting is organized by Biophysical Society and will be held from Feb 20 - 24, 2021 at Boston Convention and Exhibition Center, Boston, Massachusetts, United States of America. Additional details will be posted as soon as they are available.
Feb 22 - 25, 2021 | Boston, Massachusetts
4th Annual Gene Therapy for Rare Disorders is organized by Hanson Wade and will be held from Feb 22 - 25, 2021 at Boston Park Plaza, Boston, Massachusetts, United States of America. Description: Gene therapies are redefining the treatment of rare diseases. However, a set of complicated and different challenges must overcome these therapeutics to achieve their commercial potential. Manufacturing With an abundance of population, higher doses required, production issues are more noticeable than ever. That’s why the 2020 agenda will devote two tracks wholly to overcoming manufacturing issues, by enabling you to, • Satisfy the supervisory expectations for CMC and analytical packages • Execute strong and scalable manufacturing processes • Check the swiftly evolving logistical and infrastructure challenges facing the space Clinical More gene therapies are in the clinic than ever before. In the context of this unprecedented progress, the event will give significant attention to clinical issues including: • Maximizing significant output from trials through creative clinical trial design • Including the patient voice into clinical development • Operating the realities of the global regulatory landscape in light of recent approvals Commercial How do you price gene therapies? This question and issues around reimbursement, payment models and the commercial realities of the space will form the basis of the commercial track, with insights that will enable you to: • Understand the payer perspective on balancing access and affordability • Contrast a variety of payment models including outcome- and performance-based payments • Evaluating the commercial realities of rare and ultra-rare disease business models Key Benefits of Attending: Implement Effective Analytical & CMC Approaches to Improve Safety, Potency & Purity Explore technical insights into the analytical approaches supporting Spark Therapeutics’ gene therapy development and understand how bluebird bio has aligned CMC with regulatory expectations to support an approval Establish Robust & Scalable Manufacturing Processes & Infrastructure to Support Increasing Demand Equip yourself for commercial manufacturing, however, you utilize capacity – from making initial ‘make vs buy’ decisions, to CMO management and facility design, validation and maintenance, with insights from Pfizer, BioMarin, and Sanofi Navigate the Complex Global Gene Therapy Regulatory Environment Learn directly from international regulatory bodies including the FDA and China’s CFDA, to understand the realities of global regulatory expectations and how regulatory oversight is adapting to technical innovations in the field Examine Innovative Financing & Reimbursement Strategies Understand the payer perspective on the reimbursement strategies that are available, which approaches are working, which are not and how future government action will impact pricing and value-based agreements, with insights from Harvard Pilgrim Health, Blue Cross Blue Shield of Massachusetts and ICER Investigate Novel Vectors to Enhance Selectivity & Efficacy While Reducing Immunogenicity Look beyond the current crop of gene therapy vectors to gain an insight into the next generation of delivery technologies with the promise to dramatically enhance the specificity of targeting, reduce costs of manufacturing and overcome immunogenicity challenges, with insights from 4D Molecular Therapeutics and Duke University School of Medicine Additional details will be posted as soon as information is available.
Mar 13 - 16, 2021 | Boston, Massachusetts
American Dental Education Association (ADEA) Annual Session and Exhibition is organized by American Dental Education Association (ADEA) and will be held during Mar 13 - 16, 2021 at Boston, Massachusetts, United States of America. Additional details will be posted as soon as they are available.
Mar 19 - 21, 2021 | CME : 22 | USD $1,600.00 | Boston, Massachusetts
The Difficult Airway Course: Emergency is organized by Airway Management Education Center (AMEC). This Onsite medical conference will be held from Mar 19 ‐ 21, 2021 at Hyatt Regency Boston, Boston, Massachusetts, United States of America. This Conference has been approved for a maximum of 22 CME Credits. Target Audience: The Difficult Airway Course: Emergency is outlined for healthcare providers along with the Emergency Physicians, all other physicians who work in the Emergency Department, Physician Assistants, Paramedics, Flight Nurses, and Respiratory Therapists Setting the Standard: Thousands of physicians worldwide come to our course for intensive training in difficult airway management. Highlights include: • Instruction by a world-class faculty. • Simple, effective airway algorithms that allow for an orderly, reproducible approach to any emergency airway. • Small group, hands-on sessions exclusively focusing on difficult and failed airways, emphasizing rescue strategies and devices. • Code AirwayTM stations: Challenging medical simulations to reinforce decision-making and skills. • Focused sessions on Pediatric Airways, Trauma, Medical Emergencies, Difficult and Failed Airways. • Detailed instruction in a variety of challenging patient scenarios: ○ elevated ICP ○ pulmonary edema ○ cardiogenic shock ○ status asthmaticus ○ foreign body in the airway ○ direct airway trauma ○ multiple trauma with shock ○ and many more. • dynamic and interactive learning environment. Hands-on Training in Crucial Airway Techniques • Percutaneous and surgical cricothyrotomy • Video laryngoscopy • Fiberoptic stylets and guides • Optically enhanced laryngoscopy • Extraglottic devices • Awake intubation • Flexible endoscopic intubation • Pediatric airway skills • Techniques for the obese patient • and more! Purpose & Objectives: Airway Management is one of the several critical skills in Emergency Medicine. This course is produced to accommodate participants with state-of-the-art information and hands-on experience that assure effective and suitable management of airway emergencies. • Get a clear conceptual framework for Difficult Airway Management in the emergency setting. • Be able to recognize the Difficult, Unanticipated/Emergency Difficult and Failed airway. • Hold a rapid and systematic approach for the management of each of these clinical dilemmas. • Be familiar with the materials and procedures needed to manage these clinical dilemmas, and when and how to use them.